GERMANTOWN, Wis.--(EON: Enhanced Online News)--Global pharmaceutical chemistry leader Cambridge Major Laboratories, Inc. (CML) is pleased to announce the appointment of Dr. Mark Sawicki as Chief Business Officer. With executive leadership responsibility for the global sales and marketing organization, Dr. Sawicki will focus on developing strategies and managing their execution to drive top line performance and P&L growth, as well as hold primary responsibility for all partnership opportunities in alignment with CML’s overall strategic vision.
“His experience driving positive outcomes for clients with projects that span from early development through commercialization was an important consideration”
“Mark brings a strong track record of driving top line results and the proven ability to build world class sales and marketing organizations,” said Brian Scanlan, President and CEO of CML. “His experience driving positive outcomes for clients with projects that span from early development through commercialization was an important consideration,” said Scanlan. “As CML continues on a high growth trajectory, it is imperative that our organization be positioned for sustained growth globally; Mark will lead the efforts to ensure we are aligned across all geographies and service offerings, to position CML for continued growth.”
“The opportunity to drive strategic initiatives and build a world-class sales and marketing organization at CML that will support our company during this time of rapid growth is really exciting” said Dr. Sawicki. “I am thrilled to be here and make a positive impact.”
Dr. Sawicki has over 15 years of experience driving results within the life science vertical. He has held key leadership positions and built highly effective sales and marketing operations in global environments. Prior to this role, Dr. Sawicki held the roles of Global Vice President, Business Development at CMC Biologics A/S, as well as Vice President, Business Development – Europe at AMRI.
Dr. Sawicki holds a Ph.D. in Structural Biology from the State University of New York at Buffalo School of Medicine and Biomedical Sciences and conducted his graduate training at the Hauptman Woodward Medical Research Institute. He earned a B.S. in Biochemistry from State University of New York at Buffalo.
About Cambridge Major Laboratories
Cambridge Major Laboratories, Inc. (CML) is a leading global chemistry outsourcing partner to the pharmaceutical and biotechnology industries. The Company produces pharmaceutical intermediates and Active Pharmaceutical Ingredients (API), from early preclinical development to commercial manufacture. Operating from FDA inspected facilities in the US and Europe, CML is organized along five key Centers of Excellence including; Process Chemistry, GMP Manufacturing, Solid State Chemistry, Analytical Services, and Quality/Regulatory Compliance. For more information, visit us at www.c-mlabs.com